U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401251) titled 'Lead Exposure Intervention Program' on Feb. 03.
Brief Summary: The goal of this clinical trial is to learn if BLL (blood lead level) screening and "healthy home" lead prevention program created in the US is adaptable to a Sub-Saharan African context. It will also work to address child lead exposure in Nairobi, Kenya. The main questions it aims to answer is:
* Can materials and protocols developed for a US audience be effective in a Sub-Saharan African one?
* Is there a difference in learning and action between groups that receive different degrees of intervention?
Researchers will compare the outcomes of a group that received lea...